INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT FILES APPLICATION FOR "CRYSTALLINE FORMS OF HER2/MUTEGFR INHIBITORS AND PROCESS FOR THEIR PREPARATION"

GENEVA, March 9 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2025/074334) for "CRYSTALLINE FORMS OF HER2/MUTEGFR INHIBITORS AND PROCESS FOR THEIR PREPARATION" on Aug 27, 2025. With publication no. WO/2026/047020, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHREYER, Lucas (c/o Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 151373 Leverkusen), HILLENBRAND, Julius Vincent (c/o Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 151373 Leverkusen), JACOBS, Tia (c/o Bay...